Intercept Pharmaceuticals Inc (ICPT)

17.99 +1.12  +6.64% NASDAQ Jul 29, 08:23 USD

Intercept Pharmaceuticals Revenue (Annual):

312.69M for Dec. 31, 2020
View 4,000+ financial data types
View Full Chart

Revenue (Annual) Chart

Export Data
Save Image
Print Image

Historical Revenue (Annual) Data

View and export this data going back to 2011. Start your Free Trial
Export Data Date Range:
Data for this Date Range  
Dec. 31, 2020 312.69M
Dec. 31, 2019 252.00M
Dec. 31, 2018 179.80M
Dec. 31, 2017 130.96M
Dec. 31, 2016 24.95M
Dec. 31, 2015 2.782M
Dec. 31, 2014 1.742M
Dec. 31, 2013 1.622M
Dec. 31, 2012 2.446M
Dec. 31, 2011 1.805M

There is no data for the selected date range.

An error occurred. Please try again by refreshing your browser or contact us with details of your problem.


Revenues Definition

Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.

Read full definition.

Revenue (Annual) Benchmarks

Insmed Inc 164.41M
Cassava Sciences Inc --
Regeneron Pharmaceuticals Inc 8.497B

Revenue (Annual) Range, Past 5 Years

Minimum 24.95M 2016
Maximum 312.69M 2020
Average 180.08M


Notable earnings before Thursday's open
SA Breaking News 07/28 10:01 ET
Are These the Next Meme Stocks?
Yahoo 06/13 06:36 ET
Intercept Names Andrew Saik CFO
MT Newswires 06/07 08:50 ET



Please note that this feature is only available as an add-on to YCharts subscriptions.

Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{}} No credit card required.

Already a subscriber? Sign in.